Ftse Mib
34.825,01
-1,62%
DAX
18.768,96
0,33%
S&P 500
5.308,13
0,09%
NASDAQ
16.794,87
0,65%
Bitcoin
70.709,75
6,69%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Bellerophon Therapeutics Inc (BLPH) Bellerophon Therapeutics Inc (BLPH) Notizie

BLPH

Bellerophon Therapeutics (BLPH)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:BLPH
DataOraFonteTitoloSimboloCompagnia
30/01/202415:29Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BLPHBellerophon Therapeutics Inc
26/01/202420:31Edgar (US Regulatory)Form SCHEDULE 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:BLPHBellerophon Therapeutics Inc
26/01/202416:46Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:BLPHBellerophon Therapeutics Inc
03/01/202419:49Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:BLPHBellerophon Therapeutics Inc
27/10/202316:50Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:BLPHBellerophon Therapeutics Inc
17/10/202302:51Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BLPHBellerophon Therapeutics Inc
16/10/202319:59Edgar (US Regulatory)Form RW - Registration Withdrawal RequestNASDAQ:BLPHBellerophon Therapeutics Inc
16/10/202319:59Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:BLPHBellerophon Therapeutics Inc
14/08/202322:30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BLPHBellerophon Therapeutics Inc
29/06/202322:06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BLPHBellerophon Therapeutics Inc
12/06/202312:45Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:BLPHBellerophon Therapeutics Inc
09/06/202322:13Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BLPHBellerophon Therapeutics Inc
08/06/202312:02Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:BLPHBellerophon Therapeutics Inc
07/06/202323:06Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:BLPHBellerophon Therapeutics Inc
02/06/202314:56Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:BLPHBellerophon Therapeutics Inc
26/05/202322:49Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:BLPHBellerophon Therapeutics Inc
25/05/202317:18Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:BLPHBellerophon Therapeutics Inc
15/05/202322:47Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:BLPHBellerophon Therapeutics Inc
28/04/202314:39Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:BLPHBellerophon Therapeutics Inc
28/04/202314:34Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:BLPHBellerophon Therapeutics Inc
03/04/202323:47Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:BLPHBellerophon Therapeutics Inc
31/03/202314:31Edgar (US Regulatory)Annual Report (10-k)NASDAQ:BLPHBellerophon Therapeutics Inc
06/03/202322:26Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:BLPHBellerophon Therapeutics Inc
15/11/202214:45TipRanksH.C. Wainwright Sticks to Its Buy Rating for Bellerophon (BLPH)NASDAQ:BLPHBellerophon Therapeutics Inc
27/09/202218:25TipRanksBLPH (NASDAQ:BLPH) Soars on FDA Nod to Lung Study Change; Street Sees 24x GainsNASDAQ:BLPHBellerophon Therapeutics Inc
12/05/202212:27TipRanksH.C. Wainwright Thinks Bellerophon’s Stock is Going to RecoverNASDAQ:BLPHBellerophon Therapeutics Inc
25/04/202214:25Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:BLPHBellerophon Therapeutics Inc
06/04/202213:40TipRanksBrookline Capital Markets Thinks Bellerophon’s Stock is Going to RecoverNASDAQ:BLPHBellerophon Therapeutics Inc
04/01/202222:11Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:BLPHBellerophon Therapeutics Inc
22/12/202123:15TipRanksBellerophon Stock Has Massive Upside Potential, Says AnalystNASDAQ:BLPHBellerophon Therapeutics Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:BLPH

La tua Cronologia

BIT
1JNPR
Juniper Networks Dl 01
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network